TipRanks
CASI Pharmaceuticals (CH:ENM)
:ENM

CASI Pharmaceuticals (ENM) Revenue

0 Followers

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had a revenue of 4.91M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 20.11M, Decreased 3.78%. In the fiscal year ending Dec 31, 2025, CASI Pharmaceuticals had annual revenue of 20.71M with -27.42% growth.
Revenue (ttm)
20.11M
Revenue Growth
P/S Ratio
0.10
Revenue/Employee
CHF96,785
Employees
214
Market Cap
CHF2.17M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
20.71M-7.83M-27.42%
Mar 31, 2025
28.54M-5.34M-15.77%
Dec 31, 2023
33.88M-9.23M-21.41%
Mar 31, 2023
43.11M12.94M+42.89%
Dec 31, 2021
30.17M15.03M+99.25%
Dec 31, 2020
15.14M11.01M+266.52%
Dec 31, 2019
4.13M+∞%
Dec 31, 2018
Dec 31, 2017